Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$410,000 |
 |
Gilead SciencesGILD |
-$1.19B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$98M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Denton Sheila A. | Oct 3, 2025 | Sell | 3,501 | $85.54 | $300,000 |
| Denton Sheila A. | Oct 2, 2025 | Sell | 599 | $87.65 | $53,000 |
| Denton Sheila A. | Sep 16, 2025 | Sell | 278 | $83.15 | $23,000 |
| Denton Sheila A. | Sep 2, 2025 | Sell | 598 | $84.97 | $51,000 |
| Denton Sheila A. | Aug 15, 2025 | Sell | 277 | $86.81 | $24,000 |
| Denton Sheila A. | Aug 4, 2025 | Sell | 598 | $75.77 | $45,000 |
| Stein Steven H | Jul 21, 2025 | Sell | 3,706 | $67.94 | $250,000 |
| Flannelly Barry P | Jul 16, 2025 | Sell | 1,340 | $68.36 | $92,000 |
| Iyengar Vijay K | Jul 16, 2025 | Sell | 983 | $68.36 | $67,000 |
| Denton Sheila A. | Jul 16, 2025 | Sell | 785 | $68.36 | $54,000 |
| Denton Sheila A. | Jul 15, 2025 | Sell | 3,330 | $69.86 | $230,000 |
| Iyengar Vijay K | Jul 15, 2025 | Sell | 1,177 | $69.86 | $82,000 |
| Flannelly Barry P | Jul 15, 2025 | Sell | 1,192 | $69.86 | $83,000 |
| Stein Steven H | Jul 14, 2025 | Sell | 14,952 | $68.47 | $1M |
| Flannelly Barry P | Jul 3, 2025 | Sell | 10,903 | $68.15 | $740,000 |
| Iyengar Vijay K | Jul 3, 2025 | Sell | 5,935 | $68.15 | $400,000 |
| Iyengar Vijay K | Jul 3, 2025 | Sell | 2,682 | $68.16 | $180,000 |
| Denton Sheila A. | Jul 2, 2025 | Sell | 599 | $68.61 | $41,000 |
| Denton Sheila A. | Jun 3, 2025 | Sell | 1,795 | $68 | $120,000 |
| Tray Thomas | Jun 2, 2025 | Sell | 651 | $64.88 | $42,000 |
| Tray Thomas | May 30, 2025 | Sell | 963 | $65.71 | $63,000 |
| Flannelly Barry P | Mar 14, 2025 | Sell | 19,147 | $67.68 | $1.3M |
| Flannelly Barry P | Mar 14, 2025 | Sell | 461 | $67.85 | $31,000 |
| Flannelly Barry P | Mar 14, 2025 | Sell | 199 | $67.88 | $14,000 |
| Denton Sheila A. | Mar 4, 2025 | Sell | 599 | $69.99 | $42,000 |
| Denton Sheila A. | Feb 26, 2025 | Sell | 9,574 | $74.07 | $710,000 |
| Denton Sheila A. | Feb 26, 2025 | Sell | 4,495 | $74.08 | $330,000 |
| Stein Steven H | Jan 21, 2025 | Sell | 12,352 | $72.69 | $900,000 |
| Tray Thomas | Dec 16, 2024 | Sell | 650 | $69.31 | $45,000 |
| Iyengar Vijay K | Nov 29, 2024 | Sell | 5,683 | $75.37 | $430,000 |
| Iyengar Vijay K | Nov 29, 2024 | Sell | 360 | $75.6 | $27,000 |
| Flannelly Barry P | Nov 6, 2024 | Sell | 2,256 | $78.21 | $180,000 |
| Flannelly Barry P | Nov 6, 2024 | Sell | 1,424 | $82 | $120,000 |
| Tray Thomas | Sep 13, 2024 | Sell | 382 | $63.37 | $24,000 |
| Dickinson Jonathan Elliott | Sep 12, 2024 | Sell | 7,333 | $62.37 | $460,000 |
| Dickinson Jonathan Elliott | Sep 12, 2024 | Sell | 1,117 | $62.3 | $70,000 |
| Tray Thomas | Sep 12, 2024 | Sell | 572 | $62.94 | $36,000 |
| Stein Steven H | Aug 12, 2024 | Sell | 11,608 | $60.63 | $700,000 |
| Iyengar Vijay K | Jul 25, 2024 | Sell | 15,571 | $70 | $1.1M |
| Flannelly Barry P | Jul 16, 2024 | Sell | 1,306 | $64.19 | $84,000 |
| Flannelly Barry P | Jul 9, 2024 | Sell | 8,148 | $60 | $490,000 |
| Flannelly Barry P | Jun 12, 2024 | Sell | 19,164 | $60 | $1.1M |
| Tray Thomas | Jun 6, 2024 | Sell | 1,093 | $58.91 | $64,000 |
| Stein Steven H | Jan 3, 2024 | Sell | 7,365 | $65.51 | $480,000 |
| Iyengar Vijay K | Jan 2, 2024 | Sell | 657 | $65 | $43,000 |
| Tray Thomas | Dec 13, 2023 | Sell | 1,067 | $62.37 | $67,000 |
| Tray Thomas | Dec 12, 2023 | Sell | 210 | $57.36 | $12,000 |
What's the latest insider transaction for Incyte?
The most recent insider transaction for Incyte was conducted by Denton Sheila A., who sold 3,501 shares on October 3, 2025 at a price of $85.54 per share.
Which insider has sold the most INCY stock over the last two years?
Flannelly Barry P has sold the most INCY stock in the last 2 years, with a total value of $4.3M.
What is the total value of insider transactions for Incyte (INCY) in the last 2 years?
The total value of insider transactions for Incyte in the last 2 years is negative, amounting to -$13M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Incyte's market confidence?
Over the last 2 years, insider transactions for Incyte have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
